Physalin B
Cat.No:IPA11070 Solarbio
CAS:23133-56-4
Molecular Formula:C28H30O9
Molecular Weight:510.53
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥95%
Appearance:Solid
Qty:
Size:
{{cart_num}}
My CartCAS:23133-56-4
Molecular Formula:C28H30O9
Molecular Weight:510.53
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥95%
Appearance:Solid
Qty:
Size:
CAS | 23133-56-4 |
Name | Physalin B |
Molecular Formula | C28H30O9 |
Molecular Weight | 510.53 |
Solubility | Slightly Soluble in Methanol |
Purity | HPLC≥95% |
Appearance | Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
Target Point | Others |
Passage | Others |
Background | Physalin B has been reported to have a wide range of biological activities and can be used to treat diseases such as inflammatory eczema and herpes. Physalin B inhibits NF-κB and NLRP3 by activating the PI3K/Akt pathway, thereby improving the inflammatory response caused by LPS-induced acute lung injury. Physalin B inhibited PDGF-BB-induced proliferation, migration and phenotypic transformation of VSMC by activating the Nrf2 pathway. Physalin B exerts antitumor activity by inhibiting LAP2α-HDAC1-mediated glioma-associated oncogene-1 deacetylation and hepatic stellate cell activation. |
Unit | Bottle |
Specification | 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.